Schedule III action affirms medical legitimacy and advances a more regulated national cannabis market TAMPA, Fla., Dec. 18, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), today applauds the historic federal action directing the rescheduling of cannabis from Schedule I to Schedule III under the Controlled Substances Act, a landmark policy shift that formally recognizes... Read More
